HCA
AGIO icon

Harbor Capital Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Harbor Capital Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.46M Buy
43,005
+5,777
+16% +$164K 0.12% 251
2025
Q4 		$1.01M Buy
37,228
+2,393
+7% +$84K 0.08% 320
2025
Q3 		$1.4M Sell
34,835
-2,189
-6% -$82.3K 0.11% 258
2025
Q2 		$1.23M Buy
37,024
+1,295
+4% +$39.3K 0.05% 404
2025
Q1 		$1.05M Buy
35,729
+1,962
+6% +$65.1K 0.05% 426
2024
Q4 		$1.11M Sell
33,767
-5,323
-14% -$250K 0.05% 427
2024
Q3 		$1.74M Buy
39,090
+6,320
+19% +$287K 0.08% 339
2024
Q2 		$1.41M Buy
32,770
+13,494
+70% +$487K 0.11% 273
2024
Q1 		$564K Buy
+19,276
New +$516K 0.07% 358

Other funds holding AGIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return